Cabot Corporation (NYSE:CBT – Get Free Report) CEO Sean Keohane sold 134,895 shares of the business’s stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the transaction, the chief executive officer owned 404,134 shares in the company, valued at $34,351,390. This represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Cabot Stock Performance
NYSE:CBT traded down $0.93 during mid-day trading on Monday, hitting $82.72. The stock had a trading volume of 351,206 shares, compared to its average volume of 470,451. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $94.53. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. The stock has a market cap of $4.27 billion, a price-to-earnings ratio of 23.30, a PEG ratio of 10.98 and a beta of 0.84. The company’s 50 day simple moving average is $87.62 and its 200 day simple moving average is $81.24.
Cabot (NYSE:CBT – Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The firm had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. During the same quarter in the previous year, the business earned $1.90 earnings per share. The business’s revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, equities research analysts forecast that Cabot Corporation will post 6.35 earnings per share for the current year.
Cabot Dividend Announcement
Analysts Set New Price Targets
A number of research firms have recently issued reports on CBT. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. Mizuho increased their price target on shares of Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a report on Friday, August 21st. UBS Group decreased their price objective on Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a report on Wednesday, August 5th. Finally, JPMorgan Chase & Co. increased their price objective on Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research report on Friday, August 7th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Cabot presently has an average rating of “Hold” and an average target price of $89.00.
View Our Latest Stock Report on CBT
Institutional Investors Weigh In On Cabot
A number of large investors have recently added to or reduced their stakes in CBT. Northwestern Mutual Wealth Management Co. acquired a new position in Cabot in the second quarter valued at about $33,000. Rothschild Investment LLC grew its stake in Cabot by 170.4% during the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after buying an additional 259 shares in the last quarter. Geneos Wealth Management Inc. increased its holdings in Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares during the period. Global Retirement Partners LLC increased its holdings in Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 466 shares during the period. Finally, Danske Bank A S acquired a new position in shares of Cabot in the 3rd quarter valued at approximately $38,000. Institutional investors and hedge funds own 93.18% of the company’s stock.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Recommended Stories
- Five stocks we like better than Cabot
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
